Trial reportBMC research notes2012
First postoperative day review after uneventful phacoemulsification cataract surgery: is it necessary?
Trial report in BMC research notes, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01247155 (First Postoperative Day Review After Uneventful Phacoemulsification), which is not on this map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
First Postoperative Day Review After Uneventful Phacoemulsification
Who cites it
8 citing papers in PubMed.
- Climate-Conscious Glaucoma Care: Strategies to Minimize the Environmental Impact in the Operating Room and in the Clinic.Journal of ophthalmology · 2025Review
- Remote follow-up after cataract surgery (CORE-RCT): study protocol of a randomized controlled trial.BMC ophthalmology · 2023Article
- Article
- [Sustainability in ophthalmology : Adaptation to the climate crisis and mitigation].Die Ophthalmologie · 2022Review
- Is a Day 1 postoperative review following ab interno Xen gel stent surgery for glaucoma needed?Clinical ophthalmology (Auckland, N.Z.) · 2018Article
- Randomized Crossover Study Showing Nurse-Led Same Day Review Replacing Next Day Review in Uneventful Phacoemulsification to Be Safe and Efficacious.Journal of ophthalmology · 2017Article
- Predictive modeling of risk factors and complications of cataract surgery.European journal of ophthalmology · 2016Article
- Is the 1-day postoperative IOP check needed post uncomplicated phacoemulsification in patients with glaucoma and ocular hypertension?Eye (London, England) · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOur purpose was to examine the value of the first postoperative day review after uneventful phacoemulsification cataract surgery.
methods291 patients who underwent uneventful phacoemulsification were randomized into two groups (ClinicalTrials.gov Identifier: NCT01247155): i) Next day review (NDR group, n = 146) and ii) No next day review (NNDR group, n = 145). The rate of complications, percentage of patients seeking non-scheduled medical consultation up to postoperative day 14, presence of any inflammation-related sign and best corrected visual acuity (BCVA) on postoperative day 28 were analyzed.
resultsIn the NDR group, 5.5% of patients developed a postoperative complication, whereas the respective rate was 6.2% in the NNDR group. The difference was not statistically significant (p = 0.791). The most frequent complications were: elevated intraocular pressure, allergy to postoperative treatment, corneal abrasion, punctuate epitheliopathy, iris prolapse and postoperative hyphema, whose rates did not differ between the two groups. The rate of patients seeking non-scheduled medical consultation up to postoperative day 14, presence of any inflammation-related sign, as well as BCVA on day 28 did not exhibit any significant differences between the study groups.
conclusionsFirst postoperative day review could be omitted in cases of uneventful cataract surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.